Jove
Visualize
Contact Us

Related Concept Videos

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
Molecular Models02:00

Molecular Models

Physical models representing molecular architectures of chemical compounds play essential roles in understanding chemistry. The use of molecular models makes it easier to visualize the structures and shapes of atoms and molecules.
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Synthetic Biology02:55

Synthetic Biology

Synthetic biology is an interdisciplinary science that involves using principles from disciplines such as engineering, molecular biology, cell biology, and systems biology. It involves remodeling existing organisms from nature or constructing completely new synthetic organisms for applications such as protein or enzyme production, bioremediation, value-added macromolecule production, and the addition of desirable traits to crops, to name a few.
Golden rice
Golden rice is a genetically modified...
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal assumptions,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Machine Learning Approach for Predicting Drug-Like Molecules Targeting Calmodulin Pathway Proteins.

Journal of chemical information and modeling·2025
Same author

PTML models of self assembled ligand free nanoparticle catalysts for cross coupling reactions.

Scientific reports·2025
Same author

First report on Quantitative Structure-Toxicity Relationship modeling approaches for the prediction of acute toxicity of various organic chemicals against rotifer species.

The Science of the total environment·2025
Same author

AQUA Tox: A web tool for predicting aquatic toxicity in rotifer species using intrinsic explainable models.

Journal of hazardous materials·2025
Same author

Drug Release Nanoparticle System Design: Data Set Compilation and Machine Learning Modeling.

ACS applied materials & interfaces·2025
Same author

Artificial Intelligence-Driven Modeling for Hydrogel Three-Dimensional Printing: Computational and Experimental Cases of Study.

Polymers·2025
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 15, 2026

Applying Cheminformatics to Develop a Structure Searchable Database of Analytical Methods
05:34

Applying Cheminformatics to Develop a Structure Searchable Database of Analytical Methods

Published on: June 6, 2025

Legal issues for chem-bioinformatics models.

Aliuska Duardo-Sanchez1, Humberto Gonzalez-Diaz

  • 1Department of Especial Public Law, Financial and Tributary Law Area, Faculty of Law, University of Santiago de Compostela, 15782 Santiago de Compostela, Spain. aliuskaduardo@yahoo.es

Frontiers in Bioscience (Elite Edition)
|January 2, 2013
PubMed
Summary

Chem-Bioinformatic models link drug structures to biological activity. This review explores their regulatory use, validation challenges, and legal protection for models and software in biosciences.

More Related Videos

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

Related Experiment Videos

Last Updated: May 15, 2026

Applying Cheminformatics to Develop a Structure Searchable Database of Analytical Methods
05:34

Applying Cheminformatics to Develop a Structure Searchable Database of Analytical Methods

Published on: June 6, 2025

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

Area of Science:

  • Bioinformatics
  • Computational Chemistry
  • Drug Discovery

Background:

  • Chem-Bioinformatic models correlate molecular structures with biological activity.
  • A judicial framework is needed for computational techniques in biosciences.
  • Current approaches lack comprehensive guidance for model validation and legal protection.

Purpose of the Study:

  • To review the regulatory applications of Chem-Bioinformatic model predictions.
  • To examine legal protection strategies for molecular models and associated software.
  • To address challenges in model validation and software taxation.

Main Methods:

  • Literature review of regulatory guidelines and validation organizations.
  • Analysis of legal frameworks for intellectual property protection of software.
  • Discussion of practical issues in model implementation and taxation.

Main Results:

  • Models serve as tools for regulatory decision-making in drug development.
  • Validation of models presents significant scientific and practical difficulties.
  • Legal protection for models and software requires specific strategies.
  • Tax implications of software use in research are considered.

Conclusions:

  • Chem-Bioinformatic models are valuable tools with regulatory potential.
  • Robust validation and clear legal protection are crucial for model adoption.
  • Further development of judicial frameworks is necessary for advancing biosciences.